{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:49:07Z","timestamp":1759160947796},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T00:00:00Z","timestamp":1250121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> The objectives of this study are to provide data regarding the prevalence of anti\u2010cyclic citrullinated peptide (CCP) antibodies in Malaysian rheumatoid arthritis (RA) patients and to correlate the levels of anti\u2010CCP antibody with the Disease Activity Score (DAS).<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> We studied the prevalence of anti\u2010CCP antibodies in 51 RA patients attending our clinic and 29 controls. We also looked for correlation between anti\u2010CCP antibody levels with the DAS and parameters such as duration of disease, rheumatoid factor (RF) and disease\u2010modifying anti rheumatic drug (DMARD) usage.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> None of the controls demonstrated anti\u2010CCP antibodies. Forty\u2010one out of 51 patients (80.4%) were positive for anti\u2010CCP antibodies. Sensitivity and specificity were 80.4% and 100% respectively in this study. Anti\u2010CCP levels correlated significantly with rheumatoid factor, but no correlation was observed with the other parameters.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Anti\u2010CCP antibody is prevalent in Malaysian RA patients at 80.4% and more sensitive than RF in our cohort of established RA patients. Even though the anti\u2010CCP levels correlated with RF, it did not show correlation with DAS.<\/jats:p>","DOI":"10.1111\/j.1756-185x.2009.01412.x","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T00:02:55Z","timestamp":1250208175000},"page":"211-215","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity"],"prefix":"10.1111","volume":"12","author":[{"given":"Sargunan","family":"SOCKALINGAM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chow Sook","family":"KHUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavai","family":"STHANESHWAR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,13]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10148"},{"key":"e_1_2_6_3_2","volume-title":"Clinical Medicine","author":"Shipley M","year":"2002"},{"key":"e_1_2_6_4_2","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"Lipsky PE","year":"2001"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.870"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10241"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.7.809"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.015990"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.012211"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11223"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.008623"},{"key":"e_1_2_6_12_2","first-page":"167","article-title":"The diagnostic and prognostic significance of autoantibodies in patients with very early arthritis","volume":"48","author":"Nell VPK","year":"2003","journal-title":"Arthritis Rheum"},{"key":"e_1_2_6_13_2","first-page":"1148","article-title":"Agreement of ACR 20 with patient self reporting disease activity indices in a clinical practice setting","volume":"48","author":"Wong AL","year":"2003","journal-title":"Arthritis Rheum"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"e_1_2_6_15_2","first-page":"30","article-title":"Targeting patients with resistant rheumatoid arthritis","author":"Bingham SJ","year":"1999","journal-title":"Rheumatology Highlights 1999-2000"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg268"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.6.1089"},{"issue":"9","key":"e_1_2_6_18_2","first-page":"1829","article-title":"Determination of anti\u2010cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis","volume":"31","author":"Low JM","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_6_19_2","first-page":"25","article-title":"The diagnostic value of anti\u2010CCP and rheumatoid factor for patients with refractory rheumatoid arthritis (RA) and RA in remission","volume":"20","author":"Wu CC","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-11-200706050-00008"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.016808"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.835"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390504"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm015"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21575"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21419"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2009.01412.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1756-185X.2009.01412.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T12:54:30Z","timestamp":1697028870000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2009.01412.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,13]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1756-185X.2009.01412.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2009.01412.x","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,13]]},"assertion":[{"value":"2009-08-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}